Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

Share Price is delayed by 15 minutes
Get Live Data
520.00    0.00 (0.00%)
Bid:
516.00
Ask:
520.00
Spread: 4.00 (0.775%)
Market Cap: £860.42m
OCI Live PriceLast checked at - London Stock Exchange

Intraday Oakley Share Chart

Director/PDMR Shareholding

19 Sep 2017 07:00

RNS Number : 0860R
Oakley Capital Investments Limited
19 September 2017
Β 

19 September 2017

Β 

Β 

Oakley Capital Investments Limited

Β 

Director Dealing

Β 

Oakley Capital Investments Limited1 (AIM:OCI, the "Company"), was notified today of the following transactions by an Alternate Director of the Company:

Β 

David Till, an Alternate Director of the Company, has purchased 75,050 ordinary shares, of 1 pence each in the Company ("Ordinary Shares") in two transactions. 17,800 were purchased on 15 September 2017 at an aggregate price of 164.00 pence per Ordinary Share and 57,250 were purchased on 18 September 2017 at an aggregate price of 164.00 pence per Ordinary Share. As a result, Mr. Till is now interested in 97,700 Ordinary Shares of the Company, representing 0.05 per cent. of the issued share capital.

Β 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Β 

1

Details of the person discharging managerial responsibilities/person closely associated

Β 

a)

Name

Β 

David Till

2

Reason for the notification

Β 

a)

Position/status

Β 

Alternate Director

b)

Initial notification/ Amendment

Β 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Name

Β 

Oakley Capital Investments Limited

b)

LEI

Β 

213800KW6MZUK12CQ815

Β 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary Shares of 1p each

Β 

Β 

Β 

Β 

BMG670131058

b)

Nature of the transactions

Β 

Β 

Acquisition

c)

Price(s) and volume(s)

Β 

Β 

Price(s)

Volume(s)

Β 164.00p

Β 

164.00p

Β 

17,800

Β 

57,250

Β 

Β 

Β 

d)

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

Β 

Β 

75,050

Β 

Β 

164.00p

e)

Date of the transactions

Β 

15 and 18 September 2017

f)

Place of the transaction

Β 

London Stock Exchange

Β 

Β 

Β 

- ends -

Β 

Β 

For further information please contact:

Β 

Oakley Capital Investments Limited

+44 20 7766 6900

Peter Dubens, Director

Steven Tredget, Investor Relations

Β 

FTI Consulting LLP

+44 20 3727 1000

Edward Bridges / Stephanie Ellis

Β 

Liberum Capital Limited (Nominated Adviser & Broker)

+44 20 3100 2000

Steve Pearce / Henry Freeman / Jill Li

Β 

Β 

Β 

1About Oakley Capital Investments Limited ("OCI")

Oakley Capital Investments Limited is a Bermudian company listed on AIM. OCI seeks to provide investors with long term capital appreciation through its investment in Oakley Capital Private Equity L.P., Oakley Capital Private Equity II, Oakley Capital Private Equity III and through co-investment opportunities.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
DSHQVLFFDKFFBBE
Date   Source Headline
3rd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20264:51 pmRNSResult of AGM
1st Jun 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSTransaction in Own Shares
26th May 20267:00 amRNSOakley Capital invests in XTEL
21st May 20267:00 amRNSTransaction in Own Shares
18th May 20267:00 amRNSTransaction in Own Shares
13th May 20267:00 amRNSTransaction in Own Shares
11th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSNotice of AGM
1st May 20267:00 amRNSTotal Voting Rights
30th Apr 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTrading update for the 3 months ended 31 March 26
24th Apr 20267:00 amRNSDirector Dealing
1st Apr 20267:00 amRNSTotal Voting Rights
31st Mar 20267:00 amRNSStandard form for notification of major holdings
17th Mar 20267:00 amRNSOakley Capital partners with Groupe Senef
17th Mar 20267:00 amRNSOakley Capital partners with Groupe Senef
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSFinal Results for the Year Ended 31 December 2025
12th Mar 20267:00 amRNSFinal Results for the Year Ended 31 December 2025
10th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSNotice of Results and Investor Presentation
3rd Mar 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSDirector Dealing
17th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 202612:05 pmRNS-RUpdate from QuotedData
11th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20263:26 pmRNSStandard form for notification of major holdings
6th Feb 20263:26 pmRNSStandard form for notification of major holdings
6th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20269:43 amRNS-RUpdate from QuotedData
4th Feb 20267:00 amRNSDirector Dealing
2nd Feb 20267:00 amRNSTotal Voting Rights
28th Jan 20267:00 amRNSTrading update for the year ended 31 December 2025
26th Jan 20267:00 amRNSStandard form for notification of major holdings
9th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20265:49 pmRNSStandard form for notification of major holdings
5th Jan 20267:00 amRNSOakley Capital invests in GLAS
5th Jan 20267:00 amRNSTotal Voting Rights
31st Dec 20257:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
24th Dec 202511:18 amRNSStandard form for notification of major holdings
24th Dec 202511:18 amRNSStandard form for notification of major holdings
24th Dec 202511:04 amRNSTransaction in Own Shares
24th Dec 202511:04 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.